The labeling for celecoxib, rofecoxib, and valdecoxib was approved by the Food and Drug Administration (FDA) in December 1998, May 1999, and November 2001, respectively. Celecoxib is the only ...

Medically reviewed by William Truswell, MD Hidradenitis suppurativa (HS) is a chronic (long-term) inflammatory skin condition ...